Article
Tumor profiling of KRAS, BRAF, and NRAS gene mutations in patients with colorectal cancer: A Lebanese major center cohort study.
Gene - 5 Aug 2022
Baba Omar, Bidikian Aram, Mukherji Deborah, Shamseddin Ali, Temraz Sally, Fakhruddin Najla, Khazzouh Mira, Ghizzawi Diana, Abdel Khalek Rabab, Zaatari Ghazi, Mahfouz Rami
Abstract excerpt
BACKGROUND: In the era of precision medicine, treatment schemes for advanced Colorectal (CRC) disease include monoclonal antibodies which block the epidermal growth factor receptor (EGFR) implicated in tumor proliferation, invasion, migration and neovascularization. Resistance to these agents has been correlated with activating downstream mutations in KRAS, BRAF and NRAS genes, among others, leading to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
